期刊文献+

肺炎支原体的耐药机制和耐药基因检测现状 被引量:4

Mechanisms of drug resistance and detection of drug resistance gene of Mycoplasma pneumoniae
原文传递
导出
摘要 肺炎支原体是社区获得性肺炎的常见病原体之一,一年四季均可发病.严重感染者可引起多器官损伤、脑炎,甚至导致死亡.目前大环内酯类抗生素是治疗儿童支原体感染的首选药物,但近年来国内外均报道其耐药现象逐渐增加.现将肺炎支原体对于大环内酯类耐药现象、耐药机制和耐药基因检测现状及展望作一综述. Mycoplasma pneumoniae is one of common pathogens in community-acquired pneumonia. Serious infected patients can have multiple organ injury, encephalitis and even death. Now macrolide antibiotics are choice drugs used for treatment of mycoplasma infection in children, but it is reported that drug resistance has been increasing in recent years. This article reviews macrolide resistance, mechanisms of drug resistance,and status and prospects of drug resistance gene detection of Mycoplasma pneumoniae.
出处 《国际呼吸杂志》 2010年第16期989-993,共5页 International Journal of Respiration
关键词 肺炎支原体 大环内酯类抗生素 耐药 基因检测 Mycoplasma pneumoniae Macrolide antibiotics Drug resistance Gene detection
  • 相关文献

参考文献51

  • 1Klement E,Talkington DF,Wasserzug O,et al.Identification of risk factors for infection in an outbreak of Mycoplasma pneumoniae respiratory tract disease.Clin Infect Dis,2006,43:1239-1245.
  • 2Waites KB,Talkington DF.Mycoplasma pneumoniae and its role as a human pathogen.Clin Microbiol Rev,2004,17:697-728.
  • 3吴移谋,叶元康.支原体学.2版.北京:人民卫生出版社,2008:119-133.
  • 4Feikin DR,Moroney JF,Talkington DF,et al.An outbreak of acute respiratory disease caused by Mycoplasma pneumoniae and adenovirus at a federal service training academy:new implications from an old scenario.Clin Infect Dis,1999,29:1545-1550.
  • 5Klausner JD,Passaro D,Rosenberg J,et al.Enhanced control of an outbreak of Mycoplasma pneumoniae pneumonia with azithromycin prophylaxis.J Infect Dis,1998,177:161-166.
  • 6Dorigo-Zetsma JW,Verkooyen RP,van Helden HP,et al.Molecular detection of Mycoplasma pneumoniae in adults with community-acquired pneumonia requiring hospitalization.J Clin Microbiol,2001,39:1184-1186.
  • 7Walter ND,Grant GB,Bandy U,et al.Community outbreak of Mycoplasma pneumoniae infection:school-based cluster of neurologic disease associated with household transmission of respiratory illness.J Infect Dis,2008,198:1365-1374.
  • 8Narita M.Pathogenesis of neurologic manifestations of Mycoplasma pneumoniae infection.Pediatr Neurol,2009,41:159-166.
  • 9Cunha BA.The atypical pneumonias:clinical diagnosis and importance.Clin Microbiol Infect,2006,12:12-24.
  • 10Critchley IA,Jones ME,Heinze PD,et al.In vitro activity of levofloxacin against contemporary clinical isolates of Legionella pneumophila,Mycoplasma pneumoniae and Chlamydia pneumoniae from North America and Europe.Clin Microbiol Infect,2002,8:214-221.

二级参考文献111

共引文献181

同被引文献46

  • 1社区获得性肺炎诊断和治疗指南[J].中华结核和呼吸杂志,2006,29(10):651-655. 被引量:3057
  • 2Gutierrez F, Masia M, Rodriguez JC, et al. Community-acquired pneumonia of mixed etiology prevalence clinical characteristics and outcome [J]. Eur J Clin Microbiol Infect Dis,2005,24(6):377-383.
  • 3Lee S W, Yang S S, Chang C S, et al. Mycoplasn a pneumonia associated acute hepatitis in an adult patient without lung infection [J]. J Chin Assoc, 2009,72(4):204-206.
  • 4Varshney AK, Chaudhury R, Kabra SK, et al .Cloning, Expression, and Immunological Characterization of the P30 Protein of Mycoplasma pneumoniae[J]. Clinical and Vaccine Immuology, 2008,15(2):215 -220.
  • 5Kathleen A T, Kelley CC, Jonas M W, et al .Comparison of nucleic acid extraction method for the detection of Mycoplasma pneumoniae [J]. Diagn Microbial Infect Dis, 2009,65(4):435-438.
  • 6Gao B, Zhao C J, Yin YD, et al. High prevalence of macrolide resistance in Mycoplasma pneumonia isolates from adult and adolesc- ent patients with respiratory tract infection in China[J].Clin Infect Dis, 2010,51(2):189-194.
  • 7Morozttmi M, Iwata S, Hasegawa K, et al. Increased macrolide resistance of Mycoplasma pneumonia in pediatric patients with community-acquired pneumonia[J]. Antimicrob Agents Chemother, 2008,52(1):348-350.
  • 8Xin D, Mi Z, Han X, et a l.Molecular mechanisms of macrolide resistance in clinical isolate of Mycoplasma pneumonia from China. [J]. Antimicrob Agents Chemother, 2009,53(5):2158-2159.
  • 9Matsuoka M, Narita M, Okazaki N, et al. Characterization and molecular analysis of macrolide-resistant Mycoplasma pneumonia clinical isolates obtained in Japan [J]. Antimicrob Agents Chemother, 2004,48(12):4624-4630.
  • 10Miyashita N, Obase Y, Burghuber C, et al.Clinical features of severe Mycoplasma pneurnoniae pneumonia in adults admitted to an intensive care uni[J]. J Med Microbial,2007,56,(Pt 12): 1625-1629.

引证文献4

二级引证文献63

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部